Partners Sas Sofinnova's Net Worth

-$12.9 Million

Estimate Recalculated Apr 17, 2024 03:18PM EST

Who is Partners Sas Sofinnova?

Partners Sas Sofinnova does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CinCor Pharma, Inc., Flexion Therapeutics Inc, HOOKIPA Pharma Inc., BioAmber Inc., and Omthera Pharmaceuticals, Inc..

SEC CIK

Partners Sas Sofinnova's CIK is 0001574139

Past Insider Trading and Trends

2013 was Partners Sas Sofinnova's most active year for acquiring shares with 8 total transactions. Partners Sas Sofinnova's most active month to acquire stocks was the month of March. 2021 was Partners Sas Sofinnova's most active year for disposing of shares, totalling 8 transactions. Partners Sas Sofinnova's most active month to dispose stocks was the month of March. 2013 saw Partners Sas Sofinnova paying a total of $18,867,314.50 for 9,708,982 shares, this is the most they've acquired in one year. In 2021 Partners Sas Sofinnova cashed out on 728,620 shares for a total of $9,467,262.23, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HOOKIPA Pharma Inc. (HOOK) Snapshot price: $0.6923

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.37%
-328.62K
$11.60
-$3,812,386.34
3.18M
Apr 21
Form 4
-1.04%
-36.83K
$13.67
-$503,570.28
3.51M
Scheduled
Mar 29
Form 4
-0.98%
-35.17K
$13.69
-$481,642.23
3.54M
Scheduled
Mar 26
Form 4
-0.79%
-28.55K
$13.12
-$374,569.19
3.58M
Scheduled
Mar 25
Form 4
-1.44%
-52.69K
$13.70
-$721,615.89
3.61M
Scheduled
Mar 24
Form 4
-1.08%
-40.00K
$13.91
-$556,476.00
3.66M
Scheduled
Mar 23
Form 4
-1.08%
-40.53K
$14.54
-$589,263.02
3.7M
Scheduled
Mar 22
Form 4
-4.26%
-166.23K
$14.60
-$2,427,739.28
3.74M
Scheduled
Mar 19
Form 4
-0.01%
-300.00
$10.00
-$3,000.00
3.91M
Scheduled
Oct 2
Form 4
-1.05%
-41.60K
$12.61
-$524,476.53
3.91M
Scheduled
Sep 15
Form 4/A
-0.08%
-3.28K
$11.78
-$38,627.58
3.96M
Scheduled
Jun 29
Form 4
-0.08%
-3.28K
$11.78
-$38,627.58
3.96M
Scheduled
Jun 29
Form 4
-0.32%
-12.48K
$11.94
-$149,101.95
3.95M
Scheduled
Jul 20
Form 4
-0.08%
-3.28K
$11.78
-$38,627.58
3.96M
Scheduled
Jun 29
Form 4
+4,707.24%
3.88M
$14.00
—
3.96M
Apr 23
Form 3
—
0
—
—
0
No matching records found

BioAmber Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+30.11%
880K
—
—
3.8M
May 14
Form 3
—
0
—
—
0
No matching records found

Omthera Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-7.16M
—
—
0
Jul 18
Form 4
∞
7.16M
$7.56
$10,065,746.50
7.16M
Apr 16
Form 4
—
0
—
—
0
Apr 11
Form 3
—
0
—
—
0
No matching records found

CinCor Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.26%
133.33K
$30.00
$3,999,990.00
4.22M
Aug 15
Form 4
∞
4.09M
$16.00
—
4.09M
Jan 11
Form 3
—
0
—
—
0
No matching records found

Flexion Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.47%
-10.00K
$20.00
-$200,000.00
2.1M
Oct 29
Form 4
∞
2.11M
$13.00
—
2.11M
Feb 18
Form 3
—
0
—
—
0
No matching records found